loading

Finanzdaten der Karyopharm Therapeutics Inc-Aktie (KPTI)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-09-30 2024-06-30 2024-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
26.37%
37.93
30.02 38.78 42.79 33.13
Operating Expenses
1.51%
62.32
63.27 65.07 70.91 66.89
Benefits Costs and Expenses
40.61%
75.14
53.44 70.83 18.93 70.42
Costs And Expenses
40.61%
75.14
53.44 70.83 18.93 70.42
Operating Income/Loss
26.67%
-24.39
-33.26 -26.28 -28.12 -33.76
Nonoperating Income/Loss
230.47%
-12.82
9.83 -5.761 51.98 -3.532
Income/Loss From Continuing Operations Before Tax
58.85%
-37.21
-23.43 -32.04 23.86 -37.29
Income Tax Expense/Benefit
11.11%
0.04
0.036 0.028 0.067 0.071
Income/Loss From Continuing Operations After Tax
58.78%
-37.25
-23.46 -32.07 23.79 -37.36
Net Income/Loss
58.78%
-37.25
-23.46 -32.07 23.79 -37.36
Preferred Stock Dividends And Other Adjustments
-
- - 5.541 -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
1.77%
0.00862
0.00847 0.125 121.03 115.45
Diluted Average Shares
1.77%
0.00862
0.00847 0.125 154.43 115.45
Basic Earnings Per Share
55.96%
-4.32
-2.77 -0.26 0.15 -0.32
Diluted Earnings Per Share
55.96%
-4.32
-2.77 -0.26 -0.20 -0.32
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - 5.541 -
$35.76
price down icon 0.90%
$86.00
price down icon 0.77%
$27.54
price down icon 0.04%
$102.78
price down icon 8.61%
$146.10
price up icon 0.73%
biotechnology ONC
$345.25
price up icon 1.01%
Kapitalisierung:     |  Volumen (24h):